ProCE Banner Activity

How to Apply BCMA-Directed Strategies and the Practical Use of BCMA-Targeted Therapies in Multiple Myeloma

Clinical Thought

Two experts discuss optimal use of currently available BCMA-targeted therapies for multiple myeloma.

Released: April 25, 2023

Share

Faculty

Suzanne Lentzsch

Suzanne Lentzsch, MD, PhD

Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Joseph Mikhael

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor
Applied Cancer Research and Drug Discovery 
Translational Genomics Research Institute 
Phoenix, Arizona
Chief Medical Officer
International Myeloma Foundation 
HonorHealth Research Institute 
Scottsdale, Arizona

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

This activity is supported by educational grants from AbbVie, Bristol Myers Squibb, GaxoSmithKline, Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC, Karyopharm Therapeutics  and Regeneron Pharamceuticals, Inc.

AbbVie

Bristol Myers Squibb

GlaxoSmithKline

Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC

Karyopharm Therapeutics

Regeneron Pharmaceuticals, Inc.

Partners

Smart Patients

ProCE Banner

Provided in partnership with Smart Patients

Faculty Disclosure

Primary Author

Suzanne Lentzsch, MD, PhD

Professor of Medicine
Division of Hematology/Oncology
Columbia University Medical Center
New York, New York

Suzanne Lentzsch, MD, PhD: consultant/advisor/speaker: Adaptive, Bristol-Myers Squibb, GlaxoSmithKline, Janssen, PerView, RedMed, Regeneron, Sanofi, Takeda; researcher: Sanofi, Zentalis; stock/stock options: Magenta, Poseida; royalties or patent beneficiary: Caelum Bioscience.

Joseph Mikhael, MD, MEd, FRCPC, FACP

Professor
Applied Cancer Research and Drug Discovery 
Translational Genomics Research Institute 
Phoenix, Arizona
Chief Medical Officer
International Myeloma Foundation 
HonorHealth Research Institute 
Scottsdale, Arizona

Joseph Mikhael, MD, MEd, FRCPC, FACP: consultant/advisor/speaker: Amgen, Bristol-Myers Squibb, Janssen, Karyopharm, Sanofi, Takeda.

Format

This program has been made available online.